Genfit Stock

Genfit EPS

The Earnings per Share (EPS) of Genfit (GNFT.PA) as of Aug 8, 2026 is 0.03 EUR. In the previous year, Earnings per Share (EPS) was -0.58 EUR — a change of -105.19% (higher).

EPS

0.03EUR

YoY

-105.19%

Last updated:

Earnings per Share (EPS) of Genfit is 2026 0.03 EUR. Earnings per Share (EPS) of Genfit was 2025 -0.58 EUR. It decreases by -105.19% higher compared to the previous year.
Access this data via the Eulerpool API

Genfit Stock analysis

What does Genfit do? Genfit SA is a French company specializing in the development of therapies for the treatment of liver diseases, specifically non-alcoholic steatohepatitis (NASH). The company was founded in 1999 and is headquartered in Loos, France. Genfit is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genfit stock

Earnings per Share (EPS) of Genfit is 0.03 EUR in 2026.

Earnings per Share (EPS) of Genfit changed from -0.58 EUR to 0.03 EUR, representing a -105.19% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Genfit since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

Income Statement — Genfit

All Key Metrics — Genfit